Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6769158

CCN(CCOc1ccc2ccnc(N)c2c1)C(=O)c1ccc(OC2CCNCC2)cc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 4/20 0.45
GSK3B P49841 2/20 0.37
DYRK1A Q13627 2/20 0.37
MLYCD O95822 1/20 0.36
KCNH2 Q12809 2/20 0.35
ROCK2 O75116 1/20 0.35
CHEK2 O96017 1/20 0.35
MAPT P10636 1/20 0.35
PDE6D O43924 1/20 0.35
EPHX2 P34913 1/20 0.34
OPRD1 P41143 1/20 0.34
CNR2 P34972 1/20 0.34
SLC6A4 P31645 1/20 0.34
KDM4E B2RXH2 1/20 0.34
F2 P00734 1/20 0.34
F10 P00742 1/20 0.34
PRKCZ Q05513 1/20 0.33
IKBKB O14920 1/20 0.33
WNT1 P04628 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6771145 0.83 ROCK1 (0.48) ROCK1GSK3BDYRK1AKCNH2ROCK2
Trifluoroacetic Acid SCHEMBL6771038 0.83 ROCK1 (0.48) ROCK1GSK3BDYRK1AKCNH2ROCK2
Trifluoroacetic Acid SCHEMBL3901004 0.74 F10 (0.55) MAPTF2F10
Trifluoroacetic Acid SCHEMBL6770954 0.73 F10 (0.63) MAPTF2F10
Trifluoroacetic Acid SCHEMBL6775615 0.72 F10 (0.60) MAPTOPRD1F2F10
Trifluoroacetic Acid SCHEMBL6770182 0.71 NPC1 (0.42) F10
Trifluoroacetic Acid SCHEMBL6775232 0.71 RAD52 (0.42) MAPTF10
SCHEMBL6770185 0.70 TBXAS1 (0.36) CHEK2CNR2KDM4EF10
Trifluoroacetic Acid SCHEMBL1869116 0.69 TBK1 (0.45) ROCK1OPRD1SLC6A4
SCHEMBL6775981 0.69 KDM4E (0.40) ROCK1KDM4EF10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6825181-B1 ORALLY ADMINISTRATED TO EXHIBIT A STRONG ANTICOAGULANT EFFECT BY INHIBITING ACTIVATED BLOOD- COAGULATION FACTOR X AJINOMOTO CO., INC. (JP) 2004-11-30 US disclosed
EP-1065200-A1 AMINOISOQUINOLINE DERIVATIVES Ajinomoto Co., Inc. (JP) 2001-01-03 EP disclosed